A carregar...
Use of convalescent plasma in COVID‐19 patients with immunosuppression
In the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel coronavirus disease 19 (COVID‐19), including among patients with innate or acquired immunosuppression. However, the assoc...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8242637/ https://ncbi.nlm.nih.gov/pubmed/34036587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16525 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|